TrademarkDir
ATRIN PHARMACEUTICALS
DEAD

Serial Number

87956313

Owner

Atrin Pharmaceuticals

Attorney

David M. Tener

First Use Date

Sep 16, 2012

Filing Date

Jun 11, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ATRIN PHARMACEUTICALS Trademark

Serial Number: 87956313 • Registration: 5660937

ATRIN PHARMACEUTICALS is a trademark filed by Atrin Pharmaceuticals on June 11, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Atrin Pharmaceuticals (3 trademarks)

Pennsylvania Biotechnology Center
Doylestown, PA 18902

Entity Type: 16

Trademark Details

Filing Date

June 11, 2018

Registration Date

January 22, 2019

First Use Anywhere

September 16, 2012

First Use in Commerce

September 16, 2012

Published for Opposition

November 6, 2018

Cancellation Date

August 1, 2025

Goods & Services

research and development of pharmaceuticals for the treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 1, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 22, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 13, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 13, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 13, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 13, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 13, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 13, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Jan 22, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 6, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 17, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2018 CNSA
ASSIGNED TO EXAMINER
Sep 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2018 NWOS
NEW APPLICATION ENTERED
Jun 14, 2018 NWAP

Related Trademarks

More from this Owner

ATRIZE

ATRIZE

ATRIZE

ATRIZE

ATREZOMIB

ATREZOMIB

ATREZOMIB

ATREZOMIB